                         SEQUENCE LISTING

<110>  ELIXIR BIOPHARMA SDN. BHD.
 
<120>  METHOD OF ISOLATING MESENCHYMAL STROMAL CELLS AND APPLICATION FOR
        TISSUE ENGINEERING

<130>  MFP1216-WO

<150>  PI2015002493
<151>  2015-10-02

<160>  10    

<170>  PatentIn version 3.5

<210>  1
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Nestin Forward Primer

<400>  1
cagcgttgga acagaggttg g                                                 21


<210>  2
<211>  23
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Nestin Reverse primer

<400>  2
tggcacaggt gtctcaaggg tag                                               23


<210>  3
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  beta Tubulin III Forward primer

<400>  3
caacagcacg gccatccagg                                                   20


<210>  4
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  beta Tubulin II Reverse Primer

<400>  4
cttggggccc tgggcctccg a                                                 21


<210>  5
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  GAD65 Forward primer

<400>  5
atgacactgg agacaaggcc                                                   20


<210>  6
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  GAD65 Reverse primer

<400>  6
ttggtagctg accattgtgg                                                   20


<210>  7
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  GAD67 Forward Primer

<400>  7
tggaagtggt ggacatactc c                                                 21


<210>  8
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  GAD67 Reverse Primer

<400>  8
aagtacttgt agcgagcagc c                                                 21


<210>  9
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Tyrosine hydroxylase Forward Primer

<400>  9
ggttcccaag aaaagtgtca g                                                 21


<210>  10
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Tyrosine hysroxylase Reverse primer

<400>  10
ggtgtagacc tccttccag                                                    19


